Reticulate Hyperpigmentation Secondary to 5-Fluorouracil and Idarubicin
September 2005 | Volume 4 | Issue 5 | Case Reports | 652 | Copyright © September 2005
Reena Jogi MD, Mary Garman MD, Josie Pielop MD, Ida Orengo MD, Sylvia Hsu MD
Although cutaneous reactions from antineoplastic therapy are common, a reticulate pattern of hyperpigmentation has
not been frequently reported in the literature. We report 2 cases of reticulate hyperpigmentation associated with cancer
chemotherapy with 5-fluorouracil and idarubicin. These 2 cases serve to raise awareness of this particular pattern
of hyperpigmentation as a potential side effect of chemotherapeutic regimens.